Happy Apheresis Awareness Day!🩸 Today, we celebrate everyone who makes a difference in apheresis medicine—from practitioners and researchers to industries, patients, and donors. Your work saves countless lives.
#ApheresisAwarenessDay#AAD2025#CelebrateApheresis
Dr. Christenson at #AABB23 highlights that “HLA Matched” can mean many things, additional platelets means the patient takes additional risk, and novel strategies to support these challenging patients.
📢 #VoxSanguinis new report alert! 📚
Discover shocking insights from 🇫🇷France's plasma data on #HEV risk in #blooddonations. 💉
⌛️ Universal HEV-RNA screening coming to France in early 2023! 🎉
📲 Get the full report on Vox Sanguinis now! 🔗 https://t.co/orDJhKiAHM
Welcome to EHA #ThinkingThursday. Our schema today is on #thalassemia#diagnosis: can you fill in the missing parts A, B and C?
More info in the 2021 Thalassaemia International Federation Guidelines for the Management of Transfusion-dependent Thalassemia: https://t.co/y3F1FoaH1y
#VoxSanguinis - Author's Highlights!
Read the report "ISBT Working Party on Red Cell Immunogenetics and Blood Group Terminology Report of Basel and three Virtual Business Meetings: Update on Blood Group Systems" by Christoph Gassner et al.
👉 https://t.co/L1i6bmniFW
Excellent paper on HIT and VITT laboratory testing from two world experts on the condition. Warkentin and Greinacher have really defined the importance and role of anti-PF4 testing. https://t.co/qlQoSTdH7M #heparin#VITT
Beyond rituximab?
In this review article, Bruno Fattizzo & Wilma Barcellini summarize the recent reports evaluating innovative therapies for warm autoimmune hemolytic anemia (wAIHA).
👉🏽New Therapies for the Treatment of Warm Autoimmune Hemolytic Anemia https://t.co/yoCsL5bKzl
Today is #WorldAIDSDay, an opportunity to support all infected with #HIV and those who have lost their lives to AIDS.
This year's theme, #Equalize, highlights that the inequalities perpetuating the AIDS pandemic are not inevitable; we can tackle them.
📣It's time to #Equalize!
Important day in the history of #haemophilia treatment. Today the first ever gene therapy for #hemophilia B has been approved by the FDA in the US. So now we have approved gene therapy for hemophilia A in Europe and hemophilia B in the US. https://t.co/J6fY49wbL9